论文部分内容阅读
目的:观察小儿喘息性疾病口服地氯雷他定对患儿血清TNF-α和IL-6的影响。方法:选取2013-2014年中山市中医院收治的60例小儿喘息性疾病的患儿,对其应用地氯雷他定分散片进行治疗,并检测、记录其血清TNF-α和IL-6的变化,并且进行比较。结果:经过治疗后,患儿血清肿瘤坏死因子α(TNF-α)和白细胞介素6(IL-6)明显降低。结论:口服地氯雷他定分散片对治疗小儿喘息性疾病,具有迅速缓解,缩短病程的临床治疗效果。
Objective: To observe the effect of oral oral loratadine on serum TNF-α and IL-6 in infants with wheezing diseases. Methods: Sixty children with asthma in children admitted to Zhongshan Hospital of Traditional Chinese Medicine from 2013 to 2014 were selected and treated with desloratadine dispersible tablets. The serum levels of TNF-α and IL-6 Change, and make a comparison. Results: After treatment, the levels of serum tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6) were significantly decreased. Conclusion: Oral desloratadine dispersible tablets for the treatment of children with wheezing diseases, with rapid remission, shorten the course of clinical treatment.